IJAR.2023.279
Type of Article: Original Research
Volume 12; Issue 1 (March 2024)
Page No.: 8862-8870
DOI: https://dx.doi.org/10.16965/ijar.2023.279
Sanger Sequencing of Exon 14 of RB1 Gene Among North Indian Children with Retinoblastoma
Honey Zahra 1, Sushma Tomar *2, Nikhil Aggarwal 3, Nishant Verma 4, Syed Tasleem Raza 5, Sanjiv Kumar Gupta 6, Rakesh Kumar Verma 7, Punita Manik 8.
1 Department of Anatomy, King George’s Medical University UP, Lucknow, India. ORCiD: 0009-0002-0343-3621
*2 Department of Anatomy, King George’s Medical University UP, Lucknow, India. ORCiD: 0000-0002-9088-3171
3 Department of Anatomy, Maulana Azad Medical College, New Delhi, India. ORCiD: 0000-0002-4653-7060
4 Department of Paediatrics, King George’s Medical University UP, Lucknow, India. ORCiD: 0000-0002-8997-1801
5 Department of Biochemistry, Era University, Lucknow, India. ORCiD: 0000-0003-1248-8974
6 Department of Ophthalmology, King George’s Medical University UP, Lucknow, India. ORCiD: 0000-0002-8543-2915
7 Department of Anatomy, King George’s Medical University UP, Lucknow, India. ORCiD: 0000-0002-8984-7587
8 Department of Anatomy, King George’s Medical University UP, Lucknow, India. ORCiD: 0000-0001-9942-250X
Corresponding Author: Dr. Sushma Tomar, Additional Professor, Department of Anatomy, King George Medical University UP, Shah Mina Road, Chowk, Lucknow, Uttar Pradesh – 226003, India. E-Mail: drsushmatomar@gmail.com
ABSTRACT
Introduction: The RB1 gene has been studied for decades. A large number of genetic analytical studies on this gene are published in the Western world, but very few studies from India are available online. RB1 is the most critical gene involved in the causation of retinoblastoma, and Exon 14 is one of the highly mutated exons of this gene. Aim: To discover the genetic variants in Exon 14 of the RB1 gene in North Indian retinoblastoma patients.
Materials and Methods: This was an inter- and intra-institutional cross-sectional observational study. The Department of Anatomy, Ophthalmology, and Paediatrics at King George’s Medical University UP, Lucknow, collaborated with the Department of Biochemistry, ERA University, Lucknow. After obtaining written informed consent from their parents or legal guardians, 40 clinically and radiologically diagnosed retinoblastoma patients were included as study participants. The age range was 12-84 months. 2 ml of peripheral venous blood was withdrawn from 29 patients, and we obtained tumour tissue from 14 patients. We isolated the genomic DNA, which was amplified by PCR, and the amplified products were sent for Sanger sequencing. Chromatograms were analyzed using the BioEdit software.
Results: Most patients (92.5%) were below five years of age. Male preponderance was seen, as there were 37.5% females and 62.5% males. In the majority of cases (72.5%), the tumor was seen unilaterally with predominant involvement of the right eye; while in 27.5% of cases, both eyes were seen affected. We did not observe any variations in the sequences of exon 14.
Conclusions: As the RB1 gene has 27 exons, therefore screening for mutations in all exons is required to reach a concrete conclusion. Genetic variants might be located in the intronic regions, which may affect the proper functioning of the RB1 gene; therefore, sequencing of the entire gene will be more helpful. Next Generation Sequencing (NGS) is preferred because of the large size of the gene.
Keywords: Retinoblastoma, DNA, PCR, RB1 gene, sequencing.
REFERENCES
[1]. Tomar S, Sethi R, Sundar G, Quah TC, Quah BL, Lai PS. Mutation spectrum of RB1 mutations in retinoblastoma cases from Singapore with implications for genetic management and counseling. PLoS One 2017;12. https://doi.org/10.1371/journal.pone.0178776
PMid:28575107 PMCid:PMC5456385
[2]. Lohmann DR, Gallie BL. Retinoblastoma. GeneReviews® 2023.
[3]. Rushlow DE, Mol BM, Kennett JY, Yee S, Pajovic S, Thériault BL, et al. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol 2013;14:327-34.
https://doi.org/10.1016/S1470-2045(13)70045-7
PMid:23498719
[4]. Singh U, Malik MA, Goswami S, Shukla S, Kaur J. Epigenetic regulation of human retinoblastoma. Tumour Biol 2016;37:14427-41.
https://doi.org/10.1007/s13277-016-5308-3
PMid:27639385
[5]. Valverde JR, Alonso J, Palacios I, Pestaña Á. RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database. BMC Genet 2005;6.
https://doi.org/10.1186/1471-2156-6-53
PMid:16269091 PMCid:PMC1298292
[6]. Chawla B, Singh R. Recent advances and challenges in the management of retinoblastoma. Indian J Ophthalmol 2017;65:133. https://doi.org/10.4103/ijo.IJO_883_16
PMid:28345569 PMCid:PMC5381292
[7]. Marković L, Bukovac A, Varošanec AM, Šlaus N, Pećina-Šlaus N. Genetics in ophthalmology: molecular blueprints of retinoblastoma. Hum Genomics 2023;17:1-15.
https://doi.org/10.1186/s40246-023-00529-w
PMid:37658463 PMCid:PMC10474694
[8]. Ibrahim NO, Saleem M, Eltayeb E, Mekki S, Elnaim EG, Idris AB, et al. Molecular Genetic Analysis of RB1 gene among Sudanese children with Retinoblastoma. BioRxiv 2019:519306.
https://doi.org/10.1101/519306
[9]. Parsam VL, Ali MJ, Honavar SG, Vemuganti GK, Kannabiran C. Splicing aberrations caused by constitutional RB1 gene mutations in retinoblastoma. J Biosci 2011;36:281-7.
https://doi.org/10.1007/s12038-011-9062-9
PMid:21654082
[10]. Kiran VS, Kannabiran C, Chakravarthi K, Vemuganti GK, Honavar SG. Mutational screening of the RB1 gene in Indian patients with retinoblastoma reveals eight novel and several recurrent mutations. Hum Mutat 2003;22:339.
https://doi.org/10.1002/humu.9181
PMid:12955724
[11]. Padma M, Kumar N, Nesargi P, Aruna Kumari B, Appaji L, Viswanathan A. Epidemiology and clinical features of retinoblastoma: A tertiary care center’s experience in India. South Asian J Cancer 2020;9:56-8.
https://doi.org/10.4103/sajc.sajc_89_19
PMid:31956625 PMCid:PMC6956589
[12]. Braggio E, Bonvicino CR, Vargas FR, Ferman S, Eisenberg ALA, Seuánez HN. Identification of three novel RB1 mutations in Brazilian patients with retinoblastoma by “exon by exon” PCR mediated SSCP analysis. J Clin Pathol 2004;57:585.
https://doi.org/10.1136/jcp.2003.014423
PMid:15166261 PMCid:PMC1770321
[13]. Gupta H, Malaichamy S, Mallipatna A, Murugan S, Jeyabalan N, Suresh Babu V, et al. Retinoblastoma genetics screening and clinical management. BMC Med Genomics 2021;14.
https://doi.org/10.1186/s12920-021-01034-6
PMid:34294096 PMCid:PMC8296631
[14]. Bonanomi MTBC, de Almeida MTA, Cristofani LM, Odone Filho V. Retinoblastoma: A Three-Year-Study at a Brazilian Medical School Hospital. Clinics (Sao Paulo) 2009;64:427.
https://doi.org/10.1590/S1807-59322009000500010
PMid:19488609 PMCid:PMC2694247
[15]. Singh U, Katoch D, Kaur S, Dogra MR, Bansal D, Kapoor R. Retinoblastoma: A Sixteen-Year Review of the Presentation, Treatment, and Outcome from a Tertiary Care Institute in Northern India. Ocul Oncol Pathol 2017;4:23-32.
https://doi.org/10.1159/000477408
PMid:29344495 PMCid:PMC575756
[16]. Kumar A, Moulik NR, Mishra RK, Kumar D. Causes, outcome and prevention of abandonment in retinoblastoma in India. Pediatr Blood Cancer 2013;60:771-5.
https://doi.org/10.1002/pbc.24454
PMid:23303533
[17]. Dimaras H, Kimani K, Dimba EAO, Gronsdahl P, White A, Chan HSL, et al. Retinoblastoma. The Lancet 2012;379:1436-46.
https://doi.org/10.1016/S0140-6736(11)61137-9
PMid:22414599
[18]. Boubacar T, Fatou S, Fousseyni T, Mariam S, Fatoumata DT, Toumani S, et al. A 30-month prospective study on the treatment of retinoblastoma in the Gabriel Toure Teaching Hospital, Bamako, Mali. Br J Ophthalmol 2010;94:467-9.
https://doi.org/10.1136/bjo.2009.159699
PMid:19822911
[19]. Leal-Leal C, Flores-Rojo M, Medina-Sansón A, Cerecedo-Díaz F, Sánchez-Félix S, González-Ramella O, et al. A multicentre report from the Mexican Retinoblastoma Group. Br J Ophthalmol 2004;88:1074-7.
https://doi.org/10.1136/bjo.2003.035642
PMid:15258028 PMCid:PMC1772266
[20]. Yeole BB, Advani S. Retinoblastoma: An Epidemiological Appraisal with Reference to a Population in Mumbai, India. Asian Pac J Cancer Prev 2002;3:17-21.
[21]. Lan X, Xu W, Tang X, Ye H, Song X, Lin L, et al. Spectrum of RB1 Germline Mutations and Clinical Features in Unrelated Chinese Patients With Retinoblastoma. Front Genet 2020;11.
https://doi.org/10.3389/fgene.2020.00142
PMid:32218800 PMCid:PMC7080181
[22]. Alonso J, Garca-Miguel P, Abelairas J, Mendiola M, Sarret E, Teresa Vendrell M, et al. Spectrum of germline RB1 gene mutations in Spanish retinoblastoma patients: Phenotypic and molecular epidemiological implications. Hum Mutat 2001;17:412-22.
https://doi.org/10.1002/humu.1117
PMid:11317357
[23]. Abidi O, Knari S, Sefri H, Charif M, Senechal A, Hamel C, et al. Mutational analysis of the RB1 gene in Moroccan patients with retinoblastoma. Mol Vis 2011;17:3541.
[24]. Nguyen HH, Nguyen HTT, Vu NP, Le QT, Pham CM, Huyen TT, Manh H, Pham HLB, Nguyen TD, Le HTT, Van Nong H. Mutational screening of germline RB1 gene in Vietnamese patients with retinoblastoma reveals three novel mutations. Mol Vis. 2018 Mar 17;24:231-238.
PMID: 29568217; PMCID: PMC5858657.
